Skip to main content
. 2019 Feb 4;80(2):214–224. doi: 10.1055/s-0039-1677865

Fig. 1.

Fig. 1

Audiogram of a 48-year-old man who developed hearing loss and tinnitus 1 month after starting induction chemotherapy with cisplatin and docetaxel. He had no preexisting hearing loss or significant occupational or recreational noise exposure. Note the precipitous drop in hearing above 2 kHz bilaterally and the preserved word recognition scores.